Lab Professionals Oppose Draft Dx Reform Bill; Lab, IVD Industry Ready To Work With Congress

Clinical laboratory professional groups are largely opposed to House discussion draftlegislation that would combine in vitro diagnostics and laboratory-developed test services (LDTs) into one, new regulated product category overseen by US FDA and the Centers for Medicare and Medicaid Services.

Meanwhile, the clinical laboratory industry appears to support the new approach but wants some changes to the draft